← Leaderboards
Andreas Scherer
Golden Helix, Inc.
$5,170,755
Attributed
$5,170,755
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,170,755 · 6
By mechanism
R44$4,464,827 · 3
R43$705,928 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Variant”
- Yunda Huang · Fred Hutchinson Cancer Center$63,914,632
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Theresa Engel · Leidos Biomedical Research, Inc.$44,839,860
- Scott Topper · Broad Institute, Inc.$40,042,399
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Evan Z Macosko · Broad Institute, Inc.$29,606,858
Research focus
VariantNext Generation SequencingSmall Business Innovation Research GrantAutomationReportingResearch Clinical TestingComputer SoftwareBioinformaticsLaboratoriesDetectionEnsureSamplingAlgorithmsDesignAdoptedCopy Number PolymorphismPositioning AttributeAdoptionData WarehouseGenomic DataCostMedical SchoolsAmericanEnvironment
Grant awards (8)
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options$1,264,651
R44 · FY2025 · HG · contact PI
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options$399,810
R43 · FY2023 · HG · contact PI
Automated and Guided Workflows for Clinical Testing Using NGS Assays$649,744
R44 · FY2020 · GM · contact PI
Integrating CNV analysis into a NextGen sequencing clinical analytics platform$881,004
R44 · FY2019 · GM · contact PI
Automated and Guided Workflows for Clinical Testing Using NGS Assays$672,214
R44 · FY2019 · GM · contact PI
Integrating CNV analysis into a NextGen sequencing clinical analytics platform$997,214
R44 · FY2018 · GM · contact PI
Automated and Guided Workflows for Clinical Testing Using NGS Assays$156,162
R43 · FY2018 · GM · contact PI
Integrating CNV analysis into a NextGen sequencing clinical analytics platform$149,956
R43 · FY2017 · GM · contact PI